Maxime Espi
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Renal Transplantation Outcomes and Treatments
Papers in
-
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 6
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Laetitia Guichard-Koppe (6 shared papers)Olivier Thaunat (8 shared papers)Denis P. Fouque (4 shared papers)Denis Maillet (2 shared papers)Stéphane Dalle (2 shared papers)Thomas Barba (3 shared papers)Xavier Charmetant (7 shared papers)Emmanuel Morélon (4 shared papers)
- Journals
- Science Translational Medicine (2 papers)Toxins (2 papers)Kidney International (2 papers)Cytometry Part A (1 paper)Journal of Medical Virology (1 paper)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Maxime Espi
15 papers receiving 413 citations
Peers
Comparison fields: 5 of 59
- Infectious Diseases 236
- Transplantation 15
- Nephrology 35
- Obstetrics and Gynecology 32
- Health 21
Countries citing papers authored by Maxime Espi
This map shows the geographic impact of Maxime Espi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Espi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Espi more than expected).
Fields of papers citing papers by Maxime Espi
This network shows the impact of papers produced by Maxime Espi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Espi. The network helps show where Maxime Espi may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxime Espi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 114 | |
| 2 | 2021 | 65 | |
| 3 | 2021 | 63 | |
| 4 | 2021 | 59 | |
| 5 | 2022 | 53 | |
| 6 | 2023 | 30 | |
| 7 | 2022 | 19 | |
| 8 | 2023 | 6 | |
| 9 | 2004 | 4 | |
| 10 | 2022 | 3 | |
| 11 | 2025 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2026 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2018 | 1 | |
| 16 | 2021 | 0 |
About Maxime Espi
Maxime Espi is a scholar working on Infectious Diseases, Immunology, Nephrology, Obstetrics and Gynecology and Oncology, having authored 16 papers that have together received 422 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers), Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (2 papers), Dialysis and Renal Disease Management (2 papers), Long-Term Effects of COVID-19 (2 papers), COVID-19 Impact on Reproduction (2 papers) and Tryptophan and brain disorders (1 paper). The work is most often cited by research in Infectious Diseases (236 citations), Transplantation (15 citations), Nephrology (35 citations), Obstetrics and Gynecology (32 citations) and Health (21 citations). Maxime Espi has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Laetitia Guichard-Koppe, Olivier Thaunat, Denis P. Fouque, Denis Maillet, Stéphane Dalle, Thomas Barba, Xavier Charmetant, Emmanuel Morélon, Pierre Jean Souquet and Anne Ovize. Their work appears in journals such as Science Translational Medicine, Toxins, Kidney International, Cytometry Part A and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.